Chondroblastoma: Is intralesional curettage with the use of adjuvants a sufficient way of therapy?

BACKGROUND: Chondroblastoma is a rare benign cartilaginous bone tumor that represents 1–2% of all primary bone tumors. It is characterized by aggressive growth, possible recurrence after surgical treatment and, in rare cases, metastasis. Surgical management is the primary treatment and includes intr...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Bone Oncol
Auteurs principaux: Deventer, Niklas, Deventer, Nils, Gosheger, Georg, de Vaal, Marieke, Budny, Tymoteusz, Laufer, Andrea, Heitkoetter, Birthe, Luebben, Timo
Format: Artigo
Langue:Inglês
Publié: Elsevier 2020
Sujets:
Review Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7750402/
https://ncbi.nlm.nih.gov/pubmed/33364155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2020.100342
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires